| Primary |
| Drug Use For Unknown Indication |
18.0% |
| Torticollis |
11.3% |
| Skin Wrinkling |
10.7% |
| Muscle Spasticity |
10.5% |
| Product Used For Unknown Indication |
6.0% |
| Muscle Spasms |
5.6% |
| Migraine |
5.4% |
| Pain |
4.2% |
| Blepharospasm |
3.9% |
| Cerebral Palsy |
3.2% |
| Hyperhidrosis |
3.1% |
| Dystonia |
2.5% |
| Hypertension |
2.5% |
| Headache |
2.5% |
| Facial Spasm |
2.2% |
| Hypertonic Bladder |
2.0% |
| Depression |
1.7% |
| Skin Cosmetic Procedure |
1.6% |
| Epilepsy |
1.5% |
| Back Pain |
1.4% |
|
| Drug Ineffective |
18.0% |
| Muscular Weakness |
14.3% |
| Therapeutic Response Decreased |
7.3% |
| Weight Decreased |
6.5% |
| Vision Blurred |
5.9% |
| Vomiting |
5.3% |
| Dysphagia |
4.2% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Death |
3.9% |
| Eyelid Ptosis |
3.7% |
| Pain |
3.5% |
| Speech Disorder |
3.2% |
| Neck Pain |
2.8% |
| Pneumonia Aspiration |
2.8% |
| Pyrexia |
2.8% |
| Rash |
2.6% |
| Pneumonia |
2.5% |
| Paralysis |
2.3% |
| Injection Site Pain |
2.2% |
| Tremor |
2.1% |
|
| Secondary |
| Torticollis |
11.3% |
| Muscle Spasticity |
10.5% |
| Pain |
9.9% |
| Drug Use For Unknown Indication |
9.8% |
| Muscle Spasms |
7.4% |
| Product Used For Unknown Indication |
4.6% |
| Cerebral Palsy |
4.4% |
| Convulsion |
4.3% |
| Dystonia |
4.0% |
| Migraine |
3.9% |
| Headache |
3.9% |
| Skin Wrinkling |
3.6% |
| Blepharospasm |
3.4% |
| Depression |
3.2% |
| Anxiety |
3.1% |
| Hypertension |
3.1% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Facial Spasm |
2.4% |
| Insomnia |
2.2% |
| Back Pain |
2.1% |
|
| Muscular Weakness |
17.2% |
| Weight Decreased |
13.5% |
| Vision Blurred |
8.0% |
| Therapeutic Response Decreased |
6.6% |
| Vomiting |
6.5% |
| Torticollis |
6.1% |
| Death |
5.0% |
| Pneumonia |
5.0% |
| Pneumonia Aspiration |
3.7% |
| Speech Disorder |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Asthenia |
2.8% |
| Facial Palsy |
2.7% |
| Radial Nerve Palsy |
2.6% |
| Pyrexia |
2.5% |
| Tremor |
2.3% |
| Dysphagia |
2.2% |
| Pain In Extremity |
2.2% |
| Unresponsive To Stimuli |
2.2% |
| Musculoskeletal Pain |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.9% |
| Multiple Sclerosis |
8.8% |
| Migraine |
7.9% |
| Pain |
5.8% |
| Drug Use For Unknown Indication |
5.5% |
| Depression |
5.3% |
| Headache |
4.6% |
| Parkinson's Disease |
4.3% |
| Muscle Spasticity |
3.9% |
| Osteoporosis |
2.8% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Crohn's Disease |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Hypertension |
2.2% |
| Fibromyalgia |
2.1% |
| Vitamin Supplementation |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Hypersensitivity |
1.8% |
| Anxiety |
1.8% |
| Torticollis |
1.7% |
|
| Urinary Tract Infection |
11.2% |
| Weight Increased |
10.1% |
| Tumour Invasion |
8.4% |
| Pulmonary Embolism |
7.9% |
| Pain |
6.7% |
| Drug Ineffective |
5.6% |
| Vomiting |
5.1% |
| Weight Decreased |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Migraine |
4.5% |
| Nausea |
3.9% |
| Fatigue |
3.4% |
| Wound Secretion |
3.4% |
| Fear |
2.8% |
| Headache |
2.8% |
| Multiple Sclerosis Relapse |
2.8% |
| Pneumonia |
2.8% |
| Syncope |
2.8% |
| Tremor |
2.8% |
| Vaginal Haemorrhage |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.0% |
| Tremor |
20.0% |
| Migraine |
13.3% |
| Polyarthritis |
13.3% |
| Depression |
6.7% |
| Dystonia |
6.7% |
| Gastritis |
6.7% |
| Hypothyroidism |
6.7% |
| Osteopenia |
6.7% |
|
| Severe Mental Retardation |
42.9% |
| Pruritus |
28.6% |
| Dysphagia |
14.3% |
| Eyelid Ptosis |
14.3% |
|
